Real-world national trends and socio-economic factors preference of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in China

BACKGROUNDS: Robust evidence have demonstrated the beneficial effect of Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in T2D patients with cardiovascular diseases and chronic kidney disease. Multiple studies analyzed patterns and predictor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Cao, Guo, Shanshan, Huo, Jiping, Gao, Yiming, Yan, Yilong, Zhao, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585197/
https://www.ncbi.nlm.nih.gov/pubmed/36277697
http://dx.doi.org/10.3389/fendo.2022.987081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585197/
https://www.ncbi.nlm.nih.gov/pubmed/36277697
http://dx.doi.org/10.3389/fendo.2022.987081

Ejemplares similares